Yongin Severance Hospital said it has connected its “cobas t 711 coagulation analyzer” to Roche Diagnostics’ “cobas connection module (CCM)” as well as immune and biochemical equipment, for the first time in the Asia-Pacific region.
Cobas t 711 coagulation analyzer is a blood clotting equipment, and CCM is Roche Diagnostics' automated connection system.
The hospital, the largest medical institution in southern Gyeonggi Province, said Thursday it has introduced Roche's integrated automatic solution for more accurate and efficient blood analysis tests conducted by its laboratory medicine.
|This laboratory at Yongin Severance Hospital has been installed with an integrated automated solution for blood analysis test, for the first time in the Asia-Pacific region.|
The integrated solution allows automated series of diagnoses with a bulk loader module, which facilitates pre-processing of blood sample testing, a preprocessor (cobas p 612), and a centrifuge (cobas p 471) connected to immune and biochemical equipment and two-way conveyor.
The tested samples move to refrigerated storage (cobas p 701) by the conveyor for reexamination and storage. The integrated solution is characterized by automatically performing the whole process from testing to storing.
The cobas t 711 connected to the CCM introduced a cassette-type reagent for blood coagulation test, which has been difficult to standardize due to many manual tasks until now.
Blood coagulation tests are required in various fields, and testers' proficiency and standardization are essential. The pre-operative tests and monitoring patients with anticoagulants, which occupy most of the tests, require precise test results.
"We are very pleased to connect cobas t 711 and Roche Diagnostics' CCM for the first time in the Asia-Pacific region at the Yongin Severance Hospital," said Johnny Tse, CEO of Roche Diagnostics Korea.
Kim Jeong-ho, director of the Department of Laboratory Medicine at the hospital, also said, "We expect the partnership between our hospital and Roche Diagnostics to contribute to improving the quality of health care services for patients and Gyeonggi Province, and to provide the best results for medical workers and patients.
<© Korea Biomedical Review, All rights reserved.>